Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. bioMerieux SA
EIR
•bioMerieux SA•February 9, 2017

bioMerieux SA – FDA EIR, Feb 9, 2017

Record Details

An FDA routine inspection of BioMerieux SA, a manufacturer of Class II in-vitro diagnostic Etest devices, was conducted from February 6-9, 2017, in La Balme Les Grottes, France. The QSIT Level II inspection, conducted under compliance program 7382.845, covered management, design, corrective and preventive actions (CAPA), and production controls. Although the inspection did not result in an FDA Form 483, several concerns were discussed with management. The firm had three recent Etest product recalls since 2015, including a Class I recall for false susceptibility and another for stability issues. While a previous FDA 483 observation regarding inadequate CAPA documentation from 2013 was corrected, the current inspection highlighted areas for improvement. These included insufficient supplier controls, specifically concerning the clear identification of antibiotic manufacturers and verification of their quality systems. Furthermore, a CAPA addressing a false susceptibility recall was closed without documented verification of effectiveness. The firm also struggled to identify the root cause for incorrect MIC specifications in Etest MX32 products and had released an Etest Oxacillin lot with a technical justification despite failed supplementary testing, which subsequently led to new complaints and a pending health hazard evaluation for a potential field action. The FDA advised the firm to strengthen supplier quality criteria and ensure comprehensive root cause analyses and effectiveness verification for all corrective actions.

Company
bioMerieux SA
Inspection date
February 9, 2017
Product type
Devices
Office
Center for Devices and Radiological Health
People
  • Emmanuel Brun (recipient)
  • Stephen D. Eich (investigator)
  • Aurelien Costa (company_representative)
  • Ivan Appriou (company_representative)
View Company Profile

ID · 9fb5d3d4-bb6d-45ad-a96c-b4fb7f91ff81

Violation Codes3
21 CFR 820.10021 CFR 820.3021 CFR 820.198

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore bioMerieux SA
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.